Immunovia AB Stock price

Equities

IMMNOV

SE0006091997

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 07:59:46 2024-03-28 am EDT 5-day change 1st Jan Change
1.368 SEK -0.15% Intraday chart for Immunovia AB -9.88% -22.80%
Sales 2021 844K 78.92K Sales 2022 1.14M 107K Capitalization 595M 55.65M
Net income 2021 -156M -14.59M Net income 2022 -168M -15.71M EV / Sales 2021 1,710 x
Net cash position 2021 254M 23.76M Net cash position 2022 68.47M 6.4M EV / Sales 2022 460 x
P/E ratio 2021
-10.9 x
P/E ratio 2022
-3.54 x
Employees 11
Yield 2021 *
-
Yield 2022
-
Free-Float 73.3%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.15%
1 week-2.98%
Current month-1.87%
1 month-8.43%
3 months-27.70%
6 months+78.59%
Current year-22.80%
More quotes
1 week
1.25
Extreme 1.248
1.52
1 month
1.15
Extreme 1.152
1.77
Current year
1.15
Extreme 1.152
3.00
1 year
0.51
Extreme 0.514
7.80
3 years
0.51
Extreme 0.514
159.60
5 years
0.51
Extreme 0.514
298.50
10 years
0.51
Extreme 0.514
298.50
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO 62 22-03-31
Chief Operating Officer 61 23-02-28
Members of the board TitleAgeSince
Director/Board Member 70 16-12-08
Chairman 67 19-12-31
Director/Board Member - 23-05-21
More insiders
Date Price Change Volume
24-03-28 1.368 -0.15% 87,403
24-03-27 1.37 +3.63% 246,447
24-03-26 1.322 -2.07% 270,261
24-03-25 1.35 +1.50% 418,681
24-03-22 1.33 -12.38% 938,951

Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:59 am EDT

More quotes
Immunovia AB (publ) is a Sweden-based diagnostic company that is developing and commercializing blood tests for the early detection of cancer and autoimmune diseases based on Immunovia's test platform called IMMray. Tests are based on antibody biomarker microarray analysis using machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a disease biomarker signature. Immunovia Dx Laboratories locations in USA and Sweden provides laboratory testing services in two accredited reference laboratories.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
  1. Stock
  2. Equities
  3. Stock Immunovia AB - Nasdaq Stockholm